These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22250455)

  • 1. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
    Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
    Nakamura Y; Matsumoto K; Sato A; Morita K
    J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
    Tani S; Tomioka H; Tsuchimoto K; Kaneda T; Kubota M; Kaneko M; Fujii H
    Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):997-1002. PubMed ID: 19195200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Saito W; Shishikura Y; Nishimaki K; Kikuchi T; Sasamori K; Kikuchi Y; Miki H
    Kansenshogaku Zasshi; 2014 Jul; 88(4):469-73. PubMed ID: 25199382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
    Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S; Ohnishi R; Suzuki T; Sano K; Kato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
    Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Itraconazole-induced hypokalemia in a patient with pulmonary aspergilloma].
    Sasaki E; Maesaki S; Kawamura S; Kakeya H; Ohno H; Hirakata Y; Tomono K; Ohzono Y; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):36-40. PubMed ID: 10087874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse alveolar hemorrhage following itraconazole injection.
    Izumikawa K; Nakano K; Kurihara S; Imamura Y; Yamamoto K; Miyazaki T; Sakamoto N; Seki M; Ishimatsu Y; Kakeya H; Yamamoto Y; Yanagihara K; Tsuchiya T; Yamasaki N; Tagawa T; Mukae H; Nagayasu T; Kohno S
    Intern Med; 2010; 49(5):497-500. PubMed ID: 20190492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
    Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
    Caillot D
    Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
    Mochizuki M; Murase S; Takahashi K; Shimada S; Kume H; Iizuka T; Fukuda M
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(1):33-9. PubMed ID: 10660641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of black vinegar on itraconazole absorption].
    Oguma T; Tabata H; Aihara K; Matsumoto M; Kagioka H; Nagano M; Fukui M
    Kansenshogaku Zasshi; 2009 Jul; 83(4):369-74. PubMed ID: 19697872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Tashiro M; Takazono T; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Kakeya H; Ando T; Ogawa K; Kishi K; Tokimatsu I; Hayashi Y; Fujiuchi S; Yanagihara K; Miyazaki Y; Ichihara K; Mukae H; Kohno S; Izumikawa K
    Clin Infect Dis; 2020 Feb; 70(5):835-842. PubMed ID: 30959519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
    Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
    J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.
    Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
    Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
    Toubai T; Tanaka J; Ota S; Kato N; Umehara S; Kahata K; Toyoshima N; Asaka M; Imamura M
    Jpn J Antibiot; 2005 Dec; 58(6):507-17. PubMed ID: 16521343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.